Picture of 3SBio logo

1530 — 3SBio News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapContrarian

Brief: 3Sbio Says Unit And Numab Collaborate To Develop Portfolio Of Novel Multi-Specific Antibodies

Dec 12 (Reuters) - 3SBio Inc  1530.HK :
    * SUNSHINE GUOJIAN AND NUMAB COLLABORATE TO DEVELOP A
PORTFOLIO OF
NOVEL MULTI-SPECIFIC ANTIBODIES

Source text for Eikon:  ID:nHKS61ZPh4 
Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on 3SBio

See all news